Pablo J. Cagnoni, CEO and President at Rubius Therapeutics, Inc. (RUBY), bought 21,000 shares at $4.70 ($99K) on 2020-04-14, disclosed to the SEC on 2020-04-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| INCY | SELL | 2026-08-14 | $1.3M | — | Filing → |
| INCY | SELL | 2026-08-07 | $1.3M | — | Filing → |
| INCY | SELL | 2026-08-04 | $1.9M | — | Filing → |